Evan Zisholtz
Chief Business Development Officer Immunai
Evan Zisholtz is Vice President of Corporate Development at Immunai, where he leads strategic partnerships, business development, and transaction activities to support the company’s AI-driven immunology platform. He has experience across biotechnology strategy and corporate development, with a focus on enabling collaborations between technology-driven companies and pharmaceutical partners to advance immunology and drug discovery programs.
Seminars
Wednesday 9th September 2026
2025/26 Deal-Making Highlights: How Did They Happen?
4:15 pm
- Representing examples of successful deal-making and successful management of alliances to foster future deals, what are the learnings?
- Sharing how early-stage programs can successfully navigate the “show me data” barrier with pharma, and the activation barrier to licencing technologies between equal sized biotech
- Debating recent regulatory and emerging technology shifts, and how these will shape licensing deals for the discussed modalities
